Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Mimedx (MDXG) over the last 11 years, with Q3 2025 value amounting to -$126000.0.

  • Mimedx's Other Non Operating Income fell 50000.0% to -$126000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$580000.0, marking a year-over-year decrease of 7008.8%. This contributed to the annual value of -$565000.0 for FY2024, which is 207307.69% down from last year.
  • As of Q3 2025, Mimedx's Other Non Operating Income stood at -$126000.0, which was down 50000.0% from -$101000.0 recorded in Q2 2025.
  • In the past 5 years, Mimedx's Other Non Operating Income ranged from a high of $16000.0 in Q4 2023 and a low of -$237000.0 during Q2 2024
  • For the 5-year period, Mimedx's Other Non Operating Income averaged around -$70571.4, with its median value being -$26500.0 (2023).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 63333.33% in 2023, then crashed by 505000.0% in 2024.
  • Quarter analysis of 5 years shows Mimedx's Other Non Operating Income stood at -$20000.0 in 2021, then soared by 85.0% to -$3000.0 in 2022, then soared by 633.33% to $16000.0 in 2023, then tumbled by 1400.0% to -$208000.0 in 2024, then surged by 39.42% to -$126000.0 in 2025.
  • Its last three reported values are -$126000.0 in Q3 2025, -$101000.0 for Q2 2025, and -$145000.0 during Q1 2025.